EMA Calls For Visual Warnings Among Measures To Restrict Valproate Use
Executive Summary
The European Medicines Agency has recommended that EU member states should introduce further restrictions on the use of valproate-containing medicines to avoid the drug's exposure in pregnancy.
You may also be interested in...
French Agency Faces Manslaughter Charges Over Valproate Birth Defects
The medicines regulator, ANSM, says it has been working to limit women’s exposure to the drug.
France Steps Up Scrutiny Of Epilepsy Drug Risks In Pregnancy
The French health authorities are looking more widely at the actual or potential risks of using anti-epileptic medicines in pregnancy or in women of child bearing age. Valproate is a particular focus, but other drugs like topiramate and pregabalin are also in the frame.
Illegal Emissions Force Sanofi Production Stoppage
Sanofi is working on technical improvements after its Mourenx site in southwest France was found to be emitting illegally high levels of solvents. Production at the site is on hold.